Biblio

Found 8 results
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Uitdehaag, B M  [Clear All Filters]
2011
Rietberg MB, van Wegen EE, Uitdehaag BM, Kwakkel G. The association between perceived fatigue and actual level of physical activity in multiple sclerosis. Mult Scler [Internet]. 2011;17:1231-1237. Available from: http://www.hubmed.org/display.cgi?uids=21586484
Uitdehaag BM, Barkhof F, Coyle PK, Gardner JD, Jeffery DR, Mikol DD. The changing face of multiple sclerosis clinical trial populations. Curr Med Res Opin [Internet]. 2011;27:1529-1537. Available from: http://www.hubmed.org/display.cgi?uids=21671851
Bosma LV, Kragt JJ, Knol DL, Polman CH, Uitdehaag BM. Clinical scales in progressive MS: predicting long-term disability. Mult Scler [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=21868487
van den Elskamp IJ, Knol DL, Uitdehaag BM, Barkhof F. Modeling MR Imaging Enhancing-Lesion Volumes in Multiple Sclerosis: Application in Clinical Trials. AJNR Am J Neuroradiol [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22051810
Bazelier MT, van Staa T, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, Bentzen J, de Vries F. The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res [Internet]. 2011;26:2271-2279. Available from: http://www.hubmed.org/display.cgi?uids=21557309
2010
Moraal B, van den Elskamp IJ, Knol DL, Uitdehaag BM, Geurts JJ, Vrenken H, Pouwels PJ, van Schijndel RA, Meier DS, Guttmann CR, et al. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Ann Neurol [Internet]. 2010;67:667-675. Available from: http://www.hubmed.org/display.cgi?uids=20437564
2007
van Winsen LM, Hooper-van Veen T, van Rossum EF, Koper JW, Barkhof F, Polman CH, Uitdehaag BM. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS. J Neuroimmunol [Internet]. 2007;186:150-155. Available from: http://www.hubmed.org/display.cgi?uids=17395275
Fabriek BO, Moller HJ, Vloet RP, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BM, van den Berg TK, Dijkstra CD. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmunol [Internet]. 2007;187:179-186. Available from: http://www.hubmed.org/display.cgi?uids=17537523